factorial design

Related by string. * Factorial : multi factorial disease . multi factorial diseases . multi factorial . factorial / designing . designed . designs . Designed . designer . Design . Designer . Designs : Environmental Design LEED . THAT THEY ARE DESIGNED . designs develops manufactures . designs develops . designs manufactures sells . Designing Women . graphic design . interior designer * *

Related by context. Frequent words. (Click for all words.) 63 blind randomized controlled 61 active comparator 60 prospective randomized controlled 59 nab paclitaxel 59 dosing regimens 59 double blinded placebo 59 placebo controlled clinical 58 placebo controlled randomized 58 randomized Phase III 58 neoadjuvant 58 tobramycin 58 dose regimens 58 subgroup analyzes 58 tipranavir 58 TORISEL 58 glatiramer acetate 58 multicentre 58 nitazoxanide 57 Phase III randomized 57 randomized controlled clinical trials 57 TELCYTA 57 noninferiority 56 chemoradiotherapy 56 tanespimycin 56 peginterferon alfa 2b 56 multicenter clinical 56 randomisation 56 dacarbazine 56 pharmacodynamics 56 dose escalation 56 NOXAFIL 56 mg kg dose 56 antihypertensive drugs 56 randomized placebo controlled 56 Phase 1a 56 multicenter randomized 56 blinded placebo controlled 56 placebo controlled studies 56 FOLFOX 55 dose escalation trial 55 placebo controlled trials 55 virologic failure 55 randomized #:# 55 phase IIb 55 randomized controlled 55 TYKERB 55 vinorelbine 55 achieved statistical significance 55 blind randomized 55 mg QD 55 thymalfasin 55 unfractionated heparin 55 FOLFIRI 55 PegIntron 55 bosentan 55 EBRT 55 FOSRENOL R 55 Combination therapy 55 CoFactor 55 #mg dose [001] 55 TRITON TIMI 55 multicenter randomized double 54 blind randomized placebo 54 Arch Intern Med 54 bortezomib 54 peg IFN 54 composite endpoint 54 peginterferon alfa 2a 54 Phase 1b trial 54 vicriviroc 54 SCH # 54 antihypertensive medications 54 logistic regression 54 randomized clinical 54 peginterferon 54 adalimumab 54 Neuradiab 54 dabigatran etexilate 54 dosing schedules 54 intravenously administered 54 epoetin alfa 54 relapsed refractory multiple myeloma 54 Azedra 54 safety tolerability pharmacokinetics 54 randomized controlled clinical 54 label dose escalation 54 interferon alfa 54 ANOVA 54 Irinotecan 54 sitagliptin 54 nephrectomy 54 dose escalation study 54 randomized 53 decitabine 53 PROMACTA 53 antithrombotic 53 sunitinib 53 dose regimen 53 plus ribavirin 53 placebo controlled 53 rHuPH#

Back to home page